Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CUBICIN for Endocarditis staphylococcal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 19 adverse event reports in the FDA FAERS database where CUBICIN was used for Endocarditis staphylococcal.

Most Reported Side Effects for CUBICIN

Side Effect Reports % Deaths Hosp.
Death 30 12.1% 30 0
Drug ineffective for unapproved indication 17 6.9% 6 9
Staphylococcal bacteraemia 17 6.9% 3 4
Drug ineffective 16 6.5% 6 6
Antimicrobial susceptibility test resistant 14 5.7% 3 4
Blood creatine phosphokinase increased 13 5.2% 0 7
Pyrexia 12 4.8% 2 8
Eosinophilic pneumonia 11 4.4% 3 4
Cardiac valve vegetation 9 3.6% 1 3
Enterococcal bacteraemia 9 3.6% 2 4
Overdose 9 3.6% 4 2
Rash 9 3.6% 3 7
Renal failure acute 9 3.6% 1 6
Myalgia 8 3.2% 2 5
Respiratory failure 8 3.2% 5 3

Other Indications for CUBICIN

Off label use (129) Staphylococcal infection (27) Endocarditis (26) Enterococcal infection (24) Product used for unknown indication (23) Staphylococcal bacteraemia (23) Osteomyelitis (15) Soft tissue infection (14) Device related infection (11) Bacterial infection (10)

Other Drugs Used for Endocarditis staphylococcal

DAPTOMYCIN (150) VANCOMYCIN (137) RIFAMPIN (72) GENTAMICIN (48) LINEZOLID (41) CEFAZOLIN (30) OXACILLIN (21) LEVOFLOXACIN (20) CEFTAROLINE FOSAMIL (18) CEFTAROLINE (16)

Related Pages

CUBICIN Full Profile All Endocarditis staphylococcal Drugs CUBICIN Demographics CUBICIN Timeline